Back to Journals » Vascular Health and Risk Management » Volume 7

Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease

Authors Mohammadi, Habibpour, Ghasemi-Rad M 

Published 7 November 2011 Volume 2011:7 Pages 661—665


Review by Single anonymous peer review

Peer reviewer comments 3

Afshin Mohammadi1, Homayoon Habibpur Sedani2, Mohammad Ghasemi-Rad3
1Department of Radiology, 2Student Research Committee, 3Genius and Talented Student Organization, Student Research Committee, Urmia University of Medical Sciences, Urmia, West-Azerbaijan, Iran

Background: Nonalcoholic fatty liver disease (NAFLD) has a high prevalence in the general population and is the most common liver disease in Western countries. It is a feature of metabolic syndrome and is characterized by excessive accumulation of fat in the liver cells.
Methods: We examined 84 consecutive middle-aged (under 45 years) patients with NAFLD and 65 control subjects matched for age, gender, and body mass index to determine carotid intima-media thickness (CIMT) and flow-mediated dilatation (FMD) in the brachial artery.
Results: There was a statistically significant difference between CIMT and percentage increase in FMD in the patient group (P = 0.002; r = 0.33) when compared with the control group (P = 0.97; r = 0.005). The mean ± standard deviation CMIT was 0.65 ± 0.09 mm in patients and 0.55 ± 0.07 mm in controls. This difference was statistically significant (P = 0.001). Mean FMD in patients was 6.4% and 15.7% in controls. This difference was statistically significant (P = 0.001).
Conclusion: This study shows that pure NAFLD without metabolic syndrome in middle-aged subjects is strongly associated with morphological (CIMT) and physiological (FMD) changes. These findings may have an important role in increasing cardiovascular risk in these patients.

Keywords: nonalcoholic fatty liver disease, carotid intima-media thickness, flow-mediated dilatation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.